Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
, 2018 Hezhao Ji +7 more
openalex +1 more source
Raltegravir: The First HIV Type 1 Integrase Inhibitor [PDF]
, 2009 Charles B. Hicks, Roy M. Gulick
openalex +1 more source
Weight gain associated with integrase stand transfer inhibitor use in women
, 2023 D. Gustafson +18 more
openalex +1 more source
Development of H51Y and E157Q mutations for integrase inhibitor resistance in a patient undergoing treatment for pulmonary tuberculosis: A case report. [PDF]
SAGE Open Med Case Rep, 2023 Farias LABG +4 more
europepmc +1 more source
Pharmacology of boosted and unboosted integrase strand transfer inhibitors for two-dose event-driven HIV prevention regimens among men [PDF]
, 2022 Richard E. Haaland +12 more
openalex +1 more source
Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis. [PDF]
PLoS One, 2023 Smith C +12 more
europepmc +1 more source
A Critical Role of the C-terminal Segment for Allosteric Inhibitor-induced Aberrant Multimerization of HIV-1 Integrase [PDF]
, 2014 Nikoloz Shkriabai +8 more
openalex +1 more source
Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir. [PDF]
Antiviral Res, 2022 Rhee SY +4 more
europepmc +1 more source
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART [PDF]
, 2018 Anne Derache +9 more
openalex +1 more source